| 1 |
Melissa Fleury |
Theravance Biopharma R&D Ip |
7 |
| 2 |
Gayathri Swaminath |
Amgen |
5 |
| 2 |
Eugene de Juan, Jr. |
Forsight Vision4 |
5 |
| #4 |
Jihee Kim |
Samsung |
3 |
| #4 |
Brian M. Fox |
Denali Therapeutics |
3 |
| #4 |
Brett G. Crockett |
Dolby Laboratories Licensing |
3 |
| #7 |
Randi K. GBUR |
Tricida |
2 |
| #7 |
Jim Fink |
Aerami Therapeutics |
2 |
| #7 |
Frank L. Brodie |
Caltech |
2 |
| #7 |
Tony SangYoung Byun |
Genzyme |
2 |
| #7 |
Signe Erickson |
Forsight Vision4 |
2 |
| #7 |
Tarunmeet Gujral |
Second Genome |
2 |
| #7 |
Andrew Wonhee Han |
Second Genome |
2 |
| #7 |
Karim Dabbagh |
Second Genome |
2 |
| #7 |
Andrew W. Goodyear |
Second Genome |
2 |
| #7 |
Yasumichi Hitoshi |
Rigel Pharmaceuticals |
2 |
| #7 |
Hariharan Lakshmanan |
Oracle |
2 |
| #7 |
Todd Zachary DeSantis |
Second Genome |
2 |
| #7 |
Sunil Sudhakaran |
NVIDIA |
2 |
| #20 |
Joshua C. Hoover |
Apple |
1 |
| #20 |
Donna Marie Stone |
Genentech |
1 |
| #20 |
Harry Sweigard |
Unity Biotechnology |
1 |
| #20 |
Carl Allen Henderson, Jr. |
Impossible Foods |
1 |
| #20 |
Matthew Clarke |
Forsight Vision6 |
1 |
| #20 |
Robert Sobecki |
Verily Life Sciences |
1 |
| #20 |
Moawia Eldeeb |
— |
1 |
| #20 |
Storrs T. Hoen |
Apple |
1 |
| #20 |
Gregory E. Leyh |
Google |
1 |
| #20 |
Ayman Naseri |
— |
1 |
| #20 |
Pam Tsuruda |
Unity Biotechnology |
1 |
| #20 |
William F. O'Keeffe |
— |
1 |
| #20 |
Vivie Lee |
Aurea Software |
1 |
| #20 |
Isidro Hotzel |
Genentech |
1 |
| #20 |
Laura Serwer |
Omniox |
1 |
| #20 |
Alexander Coriano, III |
E. &J. Gallo Winery |
1 |
| #20 |
Mehnaz Khan |
Sonova Ag |
1 |
| #20 |
Jamie Dananberg |
Unity Biotechnology |
1 |
| #20 |
Jill Hopkins |
Unity Biotechnology |
1 |
| #20 |
Alain Romero |
Respira Therapeutics |
1 |
| #20 |
Hui Wu |
— |
1 |